Literature DB >> 681585

The association between blood pressure and serum cholesterol in healthy men: the Oslo study.

I Hjermann, A Helgeland, I Holme, P G Lund-Larsen, P Leren.   

Abstract

The association between serum cholesterol and blood pressure (BP) has been studied in 16 525 men. The study reveals that these Oslo men in their forties present with a serum cholesterol value which is on average 0.71 mmol/l (27.4 mg/100 ml) higher at diastolic BP greater than 110 mmHg than at BP less than 70 mmHg. According to earlier studies in Oslo, this cholesterol difference alone imparts a 10-year myocardial infarction morbidity difference of 25--30%. These findings might be of practical importance for epidemiological studies and for preventive measures against the two factors. The influence of other variables on the association between blood pressure and cholesterol has been studied in a multivariate analysis. Of these variables, only body mass index and serum triglycerides significantly influence the relationship between blood pressure and cholesterol, whereas age, cigarette smoking, non-fasting blood sugar, season, socioeconomic status, and physical activity at work and leisure do not influence the correlation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681585      PMCID: PMC1060929          DOI: 10.1136/jech.32.2.117

Source DB:  PubMed          Journal:  J Epidemiol Community Health (1978)        ISSN: 0141-7681


  10 in total

1.  The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study.

Authors:  I Hjermann; A Helgeland; I Holme; G Lung-Larsen; P Leren
Journal:  Acta Med Scand       Date:  1976

2.  The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.

Authors:  P Leren; E M Askevold; O P Foss; A Froili; D Grymyr; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen; K R Norum
Journal:  Acta Med Scand Suppl       Date:  1975

3.  Mean blood pressure and its relation to other factors determined at a routine executive health examination.

Authors:  G Pincherle; D Robinson
Journal:  J Chronic Dis       Date:  1974-07

4.  Multivariate analysis of risk factors for coronary heart disease.

Authors:  L Wilhelmsen; H Wedel; G Tibblin
Journal:  Circulation       Date:  1973-11       Impact factor: 29.690

5.  Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49.

Authors:  K Westlund; R Nicolaysen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

6.  Serum cholesterol in a national sample of U.S. adults: a study from prevalence data of its relationship to physique, blood pressure, blood glucose and other variables.

Authors:  R M Acheson; J T Baird
Journal:  Int J Epidemiol       Date:  1973       Impact factor: 7.196

7.  A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66.

Authors:  H Natvig; C F Borchgrevink; J Dedichen; P A Owren; E H Schiotz; K Westlund
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Coronary risk factors and socioeconomic status. The Oslo study.

Authors:  I Holme; A Helgeland; I Hjermann; P G Lund-Larsen; P Leren
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

9.  Coronary risk factors in a community. Findings in Tecumseh, Michigan.

Authors:  L D Ostrander; D E Lamphiear
Journal:  Circulation       Date:  1976-01       Impact factor: 29.690

10.  The relationship between blood pressure and biochemical risk factors in a general population.

Authors:  C J Bulpitt; C Hodes; M G Everitt
Journal:  Br J Prev Soc Med       Date:  1976-09
  10 in total
  4 in total

1.  Preventive medicine in primary care: management of hyperlipidaemia.

Authors:  B Lewis
Journal:  Br J Gen Pract       Date:  1992-02       Impact factor: 5.386

2.  Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.

Authors:  A Steinmetz; A Kirklies; G Schlosser; W Cassel; J H Peter; K Ehlenz; J R Schäfer; P V Wichert; H Kaffarnik
Journal:  Clin Investig       Date:  1993-02

3.  Plasma lipids and lipoproteins and essential hypertension.

Authors:  M Flesch; A Sachinidis; Y D Ko; K Kraft; H Vetter
Journal:  Clin Investig       Date:  1994-12

4.  A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk.

Authors:  Ying Li; Xiao-hui Li; Zhi-jun Huang; Guo-ping Yang; Guo-gang Zhang; Shui-ping Zhao; Ying Guo; Shi-juan Lu; Jian-lin Ma; Fan-bo Meng; Ping Chen; Hong Yuan
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.